Procter & Gamble Health Q1 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
6,790.20
-59.80 (-0.87%)
-59.80 (-0.87%)Volume158.00
Updated: Fri 17 Jul, 2026 | 15:27:52
NSE
6,810-44.50 (-0.65%)
-44.50 (-0.65%)Volume7.00 K
Updated: Fri 17 Jul, 2026 | 15:29:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Procter & Gamble Health Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 253.84 | 241.03 | 7.82% | 205.14 | N/A |
| Depreciation/ Amortization | 5.44 | 6.17 | 1.30% | 5.77 | N/A |
| Operating Income | 84.90 | 129.42 | 12.38% | 108.27 | N/A |
| Net Income | 66.18 | 94.60 | 8.17% | 82.33 | N/A |
| Other Operating Expenses Total | 98.40 | 91.13 | 19.19% | 65.10 | N/A |
| Net Income Before Taxes | 88.81 | 133.21 | 13.09% | 111.40 | N/A |
| Total Revenue | 338.74 | 370.45 | 8.92% | 313.41 | N/A |
| Selling/ General/ Admin Expenses Total | 56.01 | 50.86 | 14.80% | 46.22 | N/A |
| Diluted Normalized EPS | 39.87 | 56.99 | 8.67% | 49.60 | N/A |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.